THE Teesside-made Covid vaccine, Novavax has been approved for UK use after suffering massive delays, it has this afternoon been confirmed.

The jab, which is being produced at the Fujifilm Diosynth plant in Billingham, near Stockton, had faced big delays after pushing back submissions for approval.

With 60m doses on order, the jab was initially set to be approved for use in the UK last year, prompting the recruitment of hundreds at the Fujifilm plant.

Read more: 'We've been abandoned': Those who took part in North East vaccine trial hit out

At the time, thousands of trial volunteers hit out as they claimed they had been left in "limbo" waiting for the jab to be approved, while the company said it was working towards approval.

Darlington and Stockton Times:

But today, the Government confirmed Novvax had been given regulatory approval by the Medicines and Healthcare products Regulatory Agency.

Sajid Javid, Health and Social Care Secretary, said: "It is great to see our world-renowned medicines regulator approve another COVID-19 vaccine.

Read more: Teesside made Novavax Covid-19 vaccine faces long delays

"I want the UK to be the best place in the world to conduct clinical trials. It’s a testament to the country’s first-rate research and development capabilities for vaccines – with tens of thousands of people taking part in clinical trials here in the UK, contributing to the invaluable research that shows our vaccines are safe and effective.

"The next step will be for the independent Joint Committee on Immunisation and Vaccination to consider its use as part of the UK COVID-19 vaccination programme."

June Raine, MHRA Chief Executive, said: "Our approval of Nuvaxovid today follows a rigorous review of the safety, quality and effectiveness of this vaccine, and expert advice from the government’s independent scientific advisory body, the Commission on Human Medicines.

"I am pleased to confirm today that this authorisation has been granted, providing access to a fifth vaccine that can be used to help protect us from COVID-19.

"We are continuing our vital safety work in monitoring the use of all COVID-19 vaccines, to ensure that their benefits in protecting people against COVID-19 disease continue to outweigh any risks.

"We also carry out independent batch testing on all the approved COVID-19 vaccines to ensure that every batch meets the expected quality standards."

On Teesside, Labour MP for Stockton North, Alex Cunningham said the approval is "great news" and that he hoped to see it rolled out to the population "as quickly as possible."

He said: “I’m delighted to hear that after a long period of uncertainty the Novavax vaccine, which is being manufactured in Billingham in my Stockton North constituency, has finally been approved by the MHRA.

"This announcement is great news: it gives us an extra layer of protection against Coronavirus and creates jobs for the local area.

“I’ve been in regular contact with Novavax about the status of the vaccine and only yesterday was told they were hopeful the MHRA would approve it soon, so it’s great this has now happened.

“I understand that Fujifilm at Billingham is gearing up to manufacture the vaccine, with the early stages of production already in motion, and I hope to see it rolled out and protecting people as quickly as possible.”

--

Keep up to date with all the latest news on our website, or follow us on Facebook, Twitter and Instagram.

You can also follow our dedicated Teesside Facebook page for all the latest in the area by clicking here.

For all the top news updates from right across the region straight to your inbox, sign up to our newsletter here.

Have you got a story for us? Contact our newsdesk on newsdesk@nne.co.uk or contact 01325 505054